Last reviewed · How we verify

Investigational varicella vaccine — Competitive Intelligence Brief

Investigational varicella vaccine (Investigational varicella vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vaccine. Area: Immunology.

phase 3 Vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Investigational varicella vaccine (Investigational varicella vaccine) — GlaxoSmithKline. This vaccine stimulates the immune system to recognize and prevent varicella-zoster virus infection by inducing protective antibodies and cell-mediated immunity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Investigational varicella vaccine TARGET Investigational varicella vaccine GlaxoSmithKline phase 3 Vaccine
Comirnaty BNT162b2 (tozinameran) Pfizer Inc. marketed vaccine SARS-CoV-2 virus 2021-08-23
Prevnar 20 pneumococcal 20-valent conjugate vaccine (PCV20) Pfizer Inc. marketed Pneumococcal conjugate vaccine Streptococcus pneumoniae capsular polysaccharides (20 serotypes) 2021-06-08
adjuvanted Arepanrix adjuvanted Arepanrix University of British Columbia marketed Adjuvanted inactivated influenza vaccine H1N1 influenza virus hemagglutinin and neuraminidase antigens
4CMenb 4CMenb CHU de Quebec-Universite Laval marketed Conjugate vaccine Neisseria meningitidis serogroup B polysaccharide capsule
Oral Polio Vaccine Oral Polio Vaccine International Centre for Diarrhoeal Disease Research, Bangladesh marketed Live attenuated vaccine
batch 3 of Ad5-nCoV batch 3 of Ad5-nCoV Jiangsu Province Centers for Disease Control and Prevention marketed viral vector vaccine SARS-CoV-2 spike protein

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 12 drugs in this class
  3. Pfizer · 6 drugs in this class
  4. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
  5. Henogen · 3 drugs in this class
  6. Pfizer Inc. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Jiangsu Province Centers for Disease Control and Prevention · 2 drugs in this class
  9. BioNTech · 2 drugs in this class
  10. Merck Sharp & Dohme LLC · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Investigational varicella vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/investigational-varicella-vaccine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: